Peripheral Lymphocyte Subsets Absolute Counts as Feasible Clinical Markers for Predicting Surgical Outcome in Gastric Cancer Patients After Laparoscopic D2 Gastrectomy: A Prospective Cohort Study

References

• Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun. 2020;40(5):205–210. doi:10.1002/cac2.12025
   PubMed Web of Science ®Google Scholar
• Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–1820. doi:10.1056/NEJMoa072252
   PubMed Web of Science ®Google Scholar
• Fuse N, Bando H, Chin K, et al. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a Phase II study. Gastric Cancer. 2017;20(2):332–340. doi:10.1007/s10120-016-0606-4
   PubMed Web of Science ®Google Scholar
• Ajani JA, D’Amico TA, Bentrem DJ, et al. NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer. Version 1.2020. Accessed October 30, 2020
   Google Scholar
• Baiocchi GL, Giacopuzzi S, Reim D, Piessen G. Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: a European Retrospective Observational Study. Ann Surg. 2020;272(5):807–813. doi:10.1097/SLA.0000000000004341
   PubMed Web of Science ®Google Scholar
• Aoyama T, Yoshikawa T, Sato T, et al. Equivalent feasibility and safety of perioperative care by ERAS in open and laparoscopy-assisted distal gastrectomy for gastric cancer: a single-institution ancillary study using the patient cohort enrolled in the JCOG0912 Phase III trial. Gastric Cancer. 2019;22(3):617–623. doi:10.1007/s10120-018-0873-3
   PubMed Web of Science ®Google Scholar
• Kang SH, Lee Y, Min SH, et al. Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: a Prospective, Randomized, Clinical Trial. Gastric Cancer Ann Surg Oncol. 2018;25(11):3231–3238. doi:10.1245/s10434-018-6625-0
   PubMed Web of Science ®Google Scholar
• Coimbra FJF, de Jesus VHF, Franco CP, et al. Predicting overall and major postoperative morbidity in gastric cancer patients. J Surg Oncol. 2019;120(8):1371–1378. doi:10.1002/jso.25743
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Yamamoto K, Hirao M, et al. Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections. Ann Surg Oncol. 2015;22(Suppl 3):S778–85. doi:10.1245/s10434-015-4820-9
   PubMedGoogle Scholar
• Kanda M. Preoperative predictors of postoperative complications after gastric cancer resection. Surg Today. 2020;50(1):3–11. doi:10.1007/s00595-019-01877-8
   PubMed Web of Science ®Google Scholar
• McSorley ST, Watt DG, Horgan PG, McMillan DC. Postoperative Systemic Inflammatory Response, Complication Severity, and Survival Following Surgery for Colorectal Cancer. Ann Surg Oncol. 2016;23(9):2832–2840. doi:10.1245/s10434-016-5204-5
   PubMed Web of Science ®Google Scholar
• Plas M, Rutgers A, van der Wal-huisman H, et al. The association between the inflammatory response to surgery and postoperative complications in older patients with cancer; a prospective prognostic factor study. J Geriatr Oncol. 2020;11(5):873–879. doi:10.1016/j.jgo.2020.01.013
   PubMed Web of Science ®Google Scholar
• Bora Makal G, Yıldırım O. Are the C-reactive protein/albumin ratio (CAR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (NLR) novel inflammatory biomarkers in the early diagnosis of postoperative complications after laparoscopic sleeve gastrectomy? Obes Res Clin Pract. 2020;14(5):467–472. doi:10.1016/j.orcp.2020.07.003
   PubMed Web of Science ®Google Scholar
• Adiamah A, Skořepa P, Weimann A, Lobo DN. The Impact of Preoperative Immune Modulating Nutrition on Outcomes in Patients Undergoing Surgery for Gastrointestinal Cancer: a Systematic Review and Meta-analysis. Ann Surg. 2019;270(2):247–256. doi:10.1097/SLA.0000000000003256
   PubMed Web of Science ®Google Scholar
• Schwegler I, Von Holzen A, Gutzwiller JP, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg. 2010;97:92–97. doi:10.1002/bjs.6805
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1–10. doi:10.1016/j.immuni.2013.07.012
   PubMed Web of Science ®Google Scholar
• Milne K, Alexander C, Webb JR. Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor infiltrating lymphocytes. J Transl Med. 2012;10:33. doi:10.1186/1479-5876-10-33
   PubMed Web of Science ®Google Scholar
• Vittimberga FJ Jr, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg. 1998;227(3):326–334. doi:10.1097/00000658-199803000-00003
   PubMed Web of Science ®Google Scholar
• Schon HT, Weiskirchen R. Immunomodulatory effects of transforming growth factor-β in the liver. Hepatobiliary Surg Nutr. 2014;3(6):386–406.
   PubMedGoogle Scholar
• Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;142:113–123. doi:10.1007/s10120-011-0042-4
   Google Scholar
• Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP; STROCSS Group. The STROCSS statement: strengthening the reporting of cohort studies in surgery. Int J Surg. 2017;46:198–202. doi:10.1016/j.ijsu.2017.08.586
   PubMed Web of Science ®Google Scholar
• Xie D, Yu C, Liu L, et al. Short-term outcomes of laparoscopic D2 lymphadenectomy with complete mesogastrium excision for advanced gastric cancer. Surg Endosc. 2016;30:5138–5139. doi:10.1007/s00464-016-4847-4
   PubMed Web of Science ®Google Scholar
• Xie D, Wang Y, Shen J, Hu J, Yin P, Gong J. Detection of carcinoembryonic antigen in peritoneal fluid of patients undergoing laparoscopic distal gastrectomy with complete mesogastric excision. Br J Surg. 2018;105:1471–1479. doi:10.1002/bjs.10881
   PubMed Web of Science ®Google Scholar
• Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868–871. doi:10.1126/science.6189183
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca2
   PubMed Web of Science ®Google Scholar
• Nicole van der W, Straatman J, Cuesta MA, Daams F, Donald L. Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature. Gastric Cancer. 2018;21(1):19–30. doi:10.1007/s10120-017-0747-0
   PubMed Web of Science ®Google Scholar
• Inokuchi M, Nakagawa M, Tanioka T, Okuno K, Gokita K, Kojima K. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis. Surg Endosc. 2018;32(2):735–742. doi:10.1007/s00464-017-5730-7
   PubMed Web of Science ®Google Scholar
• Lee HJ, Hyung WJ, Yang HK, et al. Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT). Ann Surg. 2019;270(6):983–991. doi:10.1097/SLA.0000000000003217
   PubMed Web of Science ®Google Scholar
• Fukuta A, Saito T, Murata S, et al. Impact of preoperative cachexia on postoperative length of stay in elderly patients with gastrointestinal cancer. Nutrition. 2019;58:65–68. doi:10.1016/j.nut.2018.06.022
   PubMed Web of Science ®Google Scholar
• Gharagozlian S, Mala T, Brekke HK, Kolbjørnsen LC, Åa U, Johnson E. Nutritional status, sarcopenia, gastrointestinal symptoms and quality of life after gastrectomy for cancer - A cross-sectional pilot study. Clin Nutr ESPEN. 2020;37:195–201. doi:10.1016/j.clnesp.2020.03.001
   PubMed Web of Science ®Google Scholar
• King R, Tuthill C. Immune Modulation with Thymosin Alpha 1 Treatment. Vitam Horm. 2016;102:151–178.
   PubMed Web of Science ®Google Scholar
• Fernandez SV, MacFarlane AW, Jillab M, et al. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Res. 2020;22(1):134. doi:10.1186/s13058-020-01371-x
   PubMed Web of Science ®Google Scholar
• Xia Y, Li W, Li Y, et al. The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer. Transl Oncol. 2020;13(12):100849. doi:10.1016/j.tranon.2020.100849
   PubMed Web of Science ®Google Scholar
• Coca S, Perez-Piqueras J, Martinez D, et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997;79(12):2320–2328. doi:10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P
   PubMed Web of Science ®Google Scholar
• Tang YP, Xie MZ, Li KZ, Li JL, Cai ZM, Hu BL. Prognostic value of peripheral blood natural killer cells in colorectal cancer. BMC Gastroenterol. 2020;20(1):31. doi:10.1186/s12876-020-1177-8
   PubMed Web of Science ®Google Scholar
• Gong Y, Fan Z, Luo G, et al. Absolute counts of peripheral lymphocyte subsets correlate with the progression-free survival and metastatic status of pancreatic neuroendocrine tumour patients. Cancer Manag Res. 2020;12:6727–6737. doi:10.2147/CMAR.S257492
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073e81. doi:10.1093/carcin/bgp127
   Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Saito H, Kono Y, Murakami Y, et al. Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil-lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819e25. doi:10.1007/s00268-017-4400-1
   Web of Science ®Google Scholar
• Miyamoto R, Inagawa S, Sano N, Tadano S, Adachi S, Yamamoto M. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 2018;44(5):607–612. doi:10.1016/j.ejso.2018.02.003
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer. Clin Nutr. 2020;39(4):1209–1217. doi:10.1016/j.clnu.2019.05.009
   PubMed Web of Science ®Google Scholar
• Shi J, Wu Z, Wu X, et al. Early Diagnosis of Anastomotic Leakage After Gastric Cancer Surgery Via Analysis of Inflammatory Factors in Abdominal Drainage [published online ahead of print, 2021 Sep 22]. Ann Surg Oncol. 2021. doi:10.1245/s10434-021-10763-y
   Web of Science ®Google Scholar
• Mori M, Shuto K, Hirano A, et al. Preoperative Neutrophil-to-Lymphocyte Ratio may Predict Postoperative Pneumonia in Stage I-III Gastric Cancer Patients After Curative Gastrectomy: a Retrospective Study. World J Surg. 2021;45(11):3359–3369. doi:10.1007/s00268-021-06264-4
   PubMed Web of Science ®Google Scholar
• Hirahara N, Tajima Y, Matsubara T, et al. Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: a Propensity Score-Matched Analysis. J Gastrointest Surg. 2021;25(5):1124–1133. doi:10.1007/s11605-020-04710-7
   PubMed Web of Science ®Google Scholar
• Wang N, Xi W, Lu S, et al. A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy. Front Oncol. 2021;11:650562. doi:10.3389/fonc.2021.650562
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang SH, Li H, et al. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol. 2013;30(1):352. doi:10.1007/s12032-012-0352-3
   PubMed Web of Science ®Google Scholar
• Clark EJ, Connor S, Taylor MA, et al. Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB. 2007;9(6):456e60.
   Google Scholar
• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010;10(2):89–102. doi:10.1038/nri2691
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486–499. doi:10.1038/nri3862
   PubMed Web of Science ®Google Scholar
• Park JW, Chang HJ, Yeo HY, et al. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters. Br J Cancer. 2020;123(4):610–618. doi:10.1038/s41416-020-0924-5
   PubMed Web of Science ®Google Scholar
• Zhuang CL, Wang SL, Huang DD, et al. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PLoS One. 2015;10(4):e0125572. doi:10.1371/journal.pone.0125572
   PubMed Web of Science ®Google Scholar
• Guner A, Kim SY, Yu JE, et al. Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: simple Is Better Than Complex. Ann Surg Oncol. 2018;25(11):3239–3247. doi:10.1245/s10434-018-6684-2
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Ge XL, Ai SC, et al. Postoperative decrease of serum albumin predicts short-term complications in patients undergoing gastric cancer resection. World J Gastroenterol. 2017;23(27):4978–4985. doi:10.3748/wjg.v23.i27.4978
   PubMed Web of Science ®Google Scholar
• Wang FH, Zhang XT, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41(8):747–795. doi:10.1002/cac2.12193
   PubMed Web of Science ®Google Scholar
• Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, Phase 2/3 trial. Lancet. 2019;393(10184):1948–1957.
   PubMed Web of Science ®Google Scholar